mynth
← DATABASE
07/2026

CLARIVATE LIFE SCIENCES & HEALTHCARE acquired by ALTARIS

UNITED STATES Software / Industry-Specific Software / Healthcare EV 500M - 1.5b USD

Context

Altaris has entered into a definitive agreement to acquire Clarivate's Life Sciences & Healthcare business through a corporate carve-out that will establish the business as an independent company under Altaris' ownership. Following completion, Altaris will support the business in its next phase of growth as a standalone life sciences intelligence platform. The transaction is consistent with Altaris' strategy of investing in healthcare businesses with strong long-term growth potential while providing the operational focus and resources required to accelerate product innovation, strengthen commercial execution and support continued expansion. At the same time, the divestiture enables Clarivate to streamline its portfolio and sharpen its strategic focus on its core businesses. The acquisition highlights the continued use of private equity-backed carve-out transactions to create independent platforms with dedicated strategic direction and enhanced growth opportunities. Completion of the transaction remains subject to customary closing conditions and regulatory approvals.

CLARIVATE LIFE SCIENCES & HEALTHCARE, which reported an EBITDA margin of LOGIN in 2026, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level LOGIN than the average currently observed in the TMT (Tech, Media, Telecom) sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Life Sciences & Healthcare (LS&H) operates as an independent data intelligence business delivering AI‑enabled solutions to the pharmaceutical, biotechnology and medical technology sectors. The portfolio comprises the Cortellis platform, which aggregates regulatory filings, clinical‑trial data, safety information and pipeline analytics to support research and development decision‑making, and the Decision Resources Group suite, which provides epidemiology, market‑forecasting and payer‑insight tools for commercialization and market‑access planning. LS&H serves roughly 2,500 organizations worldwide, including the top twenty global pharmaceutical manufacturers, as well as mid‑size biotech firms and device innovators that require integrated insight across the drug and device lifecycle. Revenue is generated through subscription licences, data‑as‑a‑service contracts and professional services that combine analytics consulting with platform integration. The company maintains data centres in North America, Europe and Asia Pacific to ensure low‑latency access for multinational clients and complies with regional data‑privacy regulations such as GDPR and HIPAA.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2026
LOGIN
LOGIN
LOGIN
2025
LOGIN
LOGIN
LOGIN

Similar deals in TMT (Tech, Media, Telecom)

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
DateAcquirerTargetCountrySectorDeal Context
07/2026BRIDGEPOINTSKELLOFRANCESoftware

Bridgepoint Development Capital has announced an investment in Skello, a French provider of a human resources management platform dedicated to frontline teams. The transaction marks a new phase in Skello’s development, with Bridgepoint becoming a lead minority shareholder alongside the founders, management team and historical investors Partech and XAnge, which are also reinvesting in the company

07/2026ARDIAN / EURAZEO / UBSHR PATHFRANCESoftware

HR Path has entered a new phase of development through a transaction led by Ardian, which is extending its long-term support for the Group through a continuation fund. The transaction reinforces the partnership established in 2024 and reflects investors' confidence in HR Path's long-term growth strategy, while allowing the company's founders, partners, and employees to retain a majority ownership position

06/2026ASYSM-WORKFRANCESoftware

The acquisition of m-work shifts Asys’s product perimeter from legacy time-and-attendance tracking into upstream collaborative workforce scheduling and hybrid physical asset optimization. Executed with follow-on programmatic M&A backing from CAPZA through its Growth Tech investment vehicle, this transaction accelerates Asys’s product roadmap by injecting native AI capabilities into its core scheduling engine to target pan-European corporate accounts

06/2026CVCCHESS.COMUNITED STATESSoftware

CVC Capital Partners has announced an investment in Chess.com, the world’s largest online chess platform, alongside General Atlantic, the company’s longstanding investor, which will remain a shareholder

06/2026PERMIRA / WARBURG PINCUSCLEARWATER ANALYTICSUNITED STATESSoftware

Clearwater Analytics has been acquired by an Investor Group led by Permira and Warburg Pincus, with participation from Francisco Partners and Temasek. The transaction was presented to Clearwater’s shareholders following a special committee review and received board approval and majority shareholder consent, resulting in the delisting of the company’s Class A common stock from the New York Stock Exchange

06/2026SCHNEIDER ELECTRICCOGNITENETHERLANDSSoftware

Schneider Electric is acquiring Cognite Holding B.V., a provider of cloud‑native industrial data and AI software, to extend its digital portfolio and reinforce its position in industrial automation. The agreement, announced in June 2026, outlines an all‑cash transaction that will transfer 100% of Cognite's share capital to Schneider, subject to customary closing conditions and regulatory approvals

06/2026VEEVA SYSTEMSCOPLIDENMARKSoftware

Veeva Systems has acquired Copli, a company specializing in artificial intelligence solutions for Medical, Legal, and Regulatory (MLR) review processes in the life sciences industry. The acquisition marks the integration of Copli into Veeva, with the immediate launch of Veeva Falcon MLR, a new AI-powered solution designed to automate the validation cycles of promotional and medical content

06/2026WALMARTVIBEUNITED STATESSoftware

Walmart has entered into an agreement to acquire Vibe, a leading connected TV advertising specialist founded by French entrepreneurs Arthur Querou and Franck Tetzlaff. The transaction, which is subject to customary regulatory approvals, is part of Walmart's strategy to bolster its advertising capabilities and accelerate the growth of its retail media ecosystem

06/2026EOS PARTNERSDROOMSGERMANYSoftware

EOS Partners has entered into an agreement to acquire a majority stake in Drooms as part of a growth capital transaction aimed at supporting the platform's next phase of expansion. The deal involves a partial ownership transfer, with co-founder and CEO Alexandre Grellier remaining at the helm of the company

06/2026MONTAGU PRIVATE EQUITYBMC HELIXUNITED STATESSoftware

Montagu has signed an agreement to acquire a majority stake in BMC Helix through a carve-out transaction from BMC Software, a company owned by KKR. The deal involves spinning off Helix from the BMC group to create a standalone entity focused on ServiceOps and artificial intelligence-powered IT operations solutions

REFERENCES

Valuation range: EV 500M - 1.5b USD

Revenue range: 250M - 500M USD

EBITDA range: 100M - 200M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of CLARIVATE LIFE SCIENCES & HEALTHCARE by ALTARIS are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: clarivate life sciences & healthcare

Acquirer: altaris